Company intelligence / Profile preview

Contrad

Lugano, Ticino, Switzerlandcontrad.ch ↗

Ownership: Private
Employees: ~12
Development stage: Commercial

Overview

The company has commercial products in regenerative medicine, with clinical data supporting their effectiveness, particularly for their ACTV8SKN® Lip Volumizer which showed statistically significant increases in lip volume, hydration, and elasticity.

Therapeutic areas: Rheumatology
Modalities: PeptidesHyaluronic acid
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

ACTV8SKN Lip Volumizer

Commercial

Indications: Cosmetic lip volume enhancement

Beyond the preview

Go deeper on Contrad.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Contrad.

Explore the full profile